Modulation of gut microbiota by probiotics to improve the efficacy of immunotherapy in hepatocellular carcinoma
Hepatocellular carcinoma, a common malignancy of the digestive system, typically progresses through a sequence of hepatitis, liver fibrosis, cirrhosis and ultimately, tumor. The interaction between gut microbiota, the portal venous system and the biliary tract, referred to as the gut-liver axis, is...
Saved in:
| Main Authors: | Ping Chen, Chengchen Yang, Ke Ren, Mingzhi Xu, Chenwei Pan, Xuewei Ye, Lanjuan Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1504948/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
by: Siqi Ren, et al.
Published: (2025-02-01) -
Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification
by: Mingyao Huang, et al.
Published: (2025-12-01) -
Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes
by: Jiexi Yan, et al.
Published: (2024-11-01) -
Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments
by: Liza Eiman, et al.
Published: (2025-08-01) -
Role of gut microbiota in thalassemia: a review of therapeutic prospects
by: Guanjun Chen, et al.
Published: (2025-03-01)